Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections – a phase I dose toxicity trial - Concepedia

Concepedia

Publication | Open Access

Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections – a phase I dose toxicity trial

DOI Full Paper Access

67

Citations

26

References

1992

Year

J.H. Scarffe, A K Ghosh, C M Heyworth, Eric M. Bonnem, Peter L. Stern, T M Dexter

British Journal of Cancer

Clinical ImmunologyInflammationCytokineSubcutaneous InjectionsImmunotoxicologyToxicity TrialImmunologyImmunomodulationImmunotherapyMedicine

References

	Year	Citations

Page 1